Synopsys, Inc. $SNPS Stake Reduced by Financial Advocates Investment Management

Financial Advocates Investment Management trimmed its stake in Synopsys, Inc. (NASDAQ:SNPS) by 65.5% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 583 shares of the semiconductor company’s stock after selling 1,108 shares during the quarter. Financial Advocates Investment Management’s holdings in Synopsys were worth $299,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of the company. Saudi Central Bank acquired a new stake in shares of Synopsys in the 1st quarter worth about $26,000. Clal Insurance Enterprises Holdings Ltd grew its position in Synopsys by 441.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 65 shares of the semiconductor company’s stock worth $28,000 after purchasing an additional 53 shares during the last quarter. Independence Bank of Kentucky increased its stake in shares of Synopsys by 120.0% in the second quarter. Independence Bank of Kentucky now owns 55 shares of the semiconductor company’s stock valued at $28,000 after purchasing an additional 30 shares during the period. Princeton Global Asset Management LLC raised its holdings in shares of Synopsys by 481.8% during the second quarter. Princeton Global Asset Management LLC now owns 64 shares of the semiconductor company’s stock valued at $33,000 after buying an additional 53 shares during the last quarter. Finally, WPG Advisers LLC acquired a new position in shares of Synopsys during the first quarter worth approximately $34,000. Institutional investors and hedge funds own 85.47% of the company’s stock.

Synopsys Price Performance

Shares of Synopsys stock opened at $417.99 on Friday. Synopsys, Inc. has a 52 week low of $365.74 and a 52 week high of $651.73. The company has a current ratio of 1.62, a quick ratio of 1.51 and a debt-to-equity ratio of 0.52. The stock has a market cap of $77.64 billion, a PE ratio of 32.81, a price-to-earnings-growth ratio of 5.02 and a beta of 1.10. The company’s 50-day moving average price is $440.31 and its two-hundred day moving average price is $507.46.

Synopsys (NASDAQ:SNPS) last announced its quarterly earnings data on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.75 by ($1.45). Synopsys had a return on equity of 10.82% and a net margin of 31.04%.The business had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.77 billion. During the same period in the prior year, the firm earned $3.43 EPS. The business’s revenue for the quarter was up 14.0% on a year-over-year basis. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. As a group, sell-side analysts anticipate that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms recently commented on SNPS. Wall Street Zen cut Synopsys from a “hold” rating to a “sell” rating in a research report on Saturday, September 13th. Weiss Ratings restated a “hold (c)” rating on shares of Synopsys in a research note on Wednesday, October 8th. Piper Sandler reduced their price objective on shares of Synopsys from $660.00 to $630.00 and set an “overweight” rating for the company in a report on Wednesday, September 10th. Bank of America reiterated an “underperform” rating and issued a $525.00 target price (down previously from $625.00) on shares of Synopsys in a research report on Wednesday, September 10th. Finally, Stifel Nicolaus dropped their price target on shares of Synopsys from $650.00 to $550.00 and set a “buy” rating on the stock in a research report on Wednesday, September 10th. Ten analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $556.33.

Insider Buying and Selling

In other news, CFO Shelagh Glaser sold 3,655 shares of the business’s stock in a transaction on Friday, September 5th. The stock was sold at an average price of $609.77, for a total transaction of $2,228,709.35. Following the sale, the chief financial officer directly owned 15,317 shares of the company’s stock, valued at $9,339,847.09. The trade was a 19.27% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Sassine Ghazi sold 11,366 shares of the company’s stock in a transaction on Tuesday, September 2nd. The shares were sold at an average price of $589.01, for a total value of $6,694,687.66. Following the sale, the chief executive officer directly owned 71,615 shares of the company’s stock, valued at approximately $42,181,951.15. This represents a 13.70% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 30,894 shares of company stock worth $16,760,783 over the last three months. Corporate insiders own 0.62% of the company’s stock.

Synopsys Company Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.